Banking and finance

Aurobindo Pharma shares down 0.55% as Sensex rises

Shares of Ltd. fell 0.55 per cent to Rs 750.35 in Friday’s session as of 01:26PM (IST) even because the fairness benchmark Sensex traded 37.89 factors increased at 59179.05.

Earlier within the day, the inventory witnessed a spot up begin to the session. The inventory quoted a 52-week excessive worth of Rs 1063.75 and a 52-week low of Rs 660.1 on NSE. Round 19444 shares modified fingers on the counter until 01:26PM (IST).

The inventory opened at Rs 755.6 and has touched an intraday excessive and low of Rs 755.65 and Rs 746.9 throughout the session thus far. The counter quoted a price-to-earnings (PE) ratio of 8.19, earnings per share (EPS) of Rs 90.87 and worth to e-book worth (PB) of two.36, whereas the return on fairness (ROE) stood at Rs 24.32.

Promoter/ FII Holding
The promoters held 51.83 per cent stake within the firm as of September 17, whereas FII and MF ownerships stood at 25.65 per cent and 9.03 per cent, respectively.

Key Financials

With a market capitalisation of Rs 43628.99 crore, the corporate operates within the Pharma – Indian business. For the quarter ended 30-Jun-2021, the corporate reported consolidated gross sales of Rs 5783.29 crore, down 4.87 per cent from the earlier quarter?s Rs 6079.6 crore and down 4.26 per cent from the identical quarter a 12 months in the past. The corporate reported internet revenue of Rs 769.97 crore for the newest quarter, down 1.36 per cent from the corresponding quarter final 12 months.

Technical Indicators
The relative energy index (RSI) of the inventory stands at 42.73. The RSI oscillates between zero and 100. Historically, it’s thought-about overbought situation when the RSI worth is above 70 and oversold situation when it’s under 30. Analysts say the RSI indicator shouldn’t be seen in isolation, because it might not be adequate to take a buying and selling name, simply the way in which a elementary analyst can’t give a “purchase” or “promote” advice utilizing a single valuation ratio.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button